By vgreene, 22 April, 2016 Labs: ✓ baseline fasting lipid panel,4 ✓ ALT, and if indicated ✓ CK. Eval/treat TG ≥500 mg/dL, unexplained ALT >3x ULN. Consider eval for secondary causes/conditions that may influence statin safety. If LDL–C ≥190 mg/dL,5 strongly consider lipid specialis
By vgreene, 22 April, 2016 Stone NJ, et al. 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the ACC/AHA Task Force on Practice Guidelines. <i>Circulation.</i> 2014;129(25 Suppl 2):S1-45.